<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2044">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134558</url>
  </required_header>
  <id_info>
    <org_study_id>201912128RIN</org_study_id>
    <nct_id>NCT05134558</nct_id>
  </id_info>
  <brief_title>Xenon-enhanced Ventilation CT-guided Radiotherapy for Lung Cancer Treatment</brief_title>
  <official_title>Xenon-enhanced Ventilation CT-guided Radiotherapy for Lung Cancer Treatment: Functional Protection of the Lung and Prevention of Radiation Pneumonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to use xenon-enhanced ventilation computed tomography (CT) to design&#xD;
      personalized functional lung avoidance radiotherapy for lung cancer patients who are&#xD;
      scheduled to receive lung radiation therapy. The investigators' goal is to optimally protect&#xD;
      the lung function of the patients and reduce the incidence of radiation pneumonitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There has been an increase in the application of radiation therapy in the treatment of lung&#xD;
      tumors; however, the associated side effect, called radiation pneumonitis, can significantly&#xD;
      reduce lung function and the quality of life of patients, eventually leading to fatal&#xD;
      consequences. The investigators aim to use xenon-enhanced ventilation computed tomography&#xD;
      (CT) to design personalized functional lung avoidance radiotherapy for lung cancer patients&#xD;
      who are scheduled to receive lung radiation therapy. The investigators' goal is to optimally&#xD;
      protect the lung function of the patients and reduce the incidence of radiation pneumonitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of radiation pneumonia</measure>
    <time_frame>Within 1 year of radiation therapy</time_frame>
    <description>Incidence of radiation pneumonia</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Radiation Therapy Complication</condition>
  <arm_group>
    <arm_group_label>Xenon-enhanced Ventilation CT-guided Radiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be receiving Xenon-enhanced Ventilation CT-guided Radiotherapy for functional lung avoidance. The doses for the tumors, lungs, and organs at risk will be examined and evaluated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Xenon-enhanced Ventilation CT-guided Radiotherapy</intervention_name>
    <description>Xenon-enhanced Ventilation CT-guided Radiotherapy for functional protection of the lung</description>
    <arm_group_label>Xenon-enhanced Ventilation CT-guided Radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 20-80 years, with lung cancer receiving thoracic radiotherapy in NTUH,&#xD;
             from February 2020 to December 2024.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The age is less than 20 years old or older than 80 years old.&#xD;
&#xD;
          -  Unstable clinical condition, unable to maintain apnea for 15 second, and history of&#xD;
             prior adverse reaction to xenon.&#xD;
&#xD;
          -  Renal insufficiency patients.&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Those who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yu-Sen Huang, Md PhD</last_name>
    <phone>+886-23123456</phone>
    <email>yusen0814@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Sen Huang, MD PhD</last_name>
      <phone>+886-23123456</phone>
      <email>yusen0814@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>November 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 14, 2021</last_update_submitted>
  <last_update_submitted_qc>November 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>Radiation Therapy</keyword>
  <keyword>Xenon-enhanced ventilation CT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

